The Endocrine Society is a trusted authority and expert on obesity. The Endocrine Society is working to reduce the prevalence of obesity in the United States by educating Congress about obesity and identifying policy options that would address this issue.
- Obesity Playbook: Early in 2023, the Endocrine Society published an educational resource for members of Congress and their staff about obesity. The Playbook was designed to be a “go-to” resource for members of Congress and their staff when they answer constituent questions about obesity and consider legislation related to obesity. The Obesity Playbook contains data on obesity prevalence, the economic cost of obesity, obesity’s impact on military readiness, policy options to address obesity, and a list of Society members who are experts in the field. Endocrine Society members Drs. Amy Rothberg, Rocio Pereira, and Jami Josefson served as advisors for the Playbook.
- Congressional Briefings: The Endocrine Society conducted a Congressional briefing for members of Congress and their staff to educate them about prevalence of obesity, its financial costs to our healthcare system, and its impact on America’s military readiness. Endocrine Society members Drs. Amy Rothberg and Ricard Correa spoke at the briefing, highlighting new data from the CDC about increasing obesity prevalence and its impact on our military.
- Treat and Reduce Obesity Act: The Endocrine Society has been working closely with the sponsors of the Treat and Reduce Obesity Act (TROA) on the bill’s reintroduction. TROA is a bipartisan bill that would improve Medicare coverage of various treatments for obesity, including anti-obesity medications. Improving access to obesity treatments is a top priority for the Society.
Learn more about the Society's advocacy surrounding obesity here.
